Investing in Medical Practices: Vision and Strategy Matter More than ‘Growth for the Sake of Growth’

By Marti Washburn Giunto, Senior Director, Health Tech
Published May 30, 2025

I attended the McGuireWoods Healthcare Private Equity and Finance Conference in May, and one thought has stuck with me: Growth for the sake of growth is starting to show a chink in its armor.
After attending the meeting, I returned home reflecting on the following takeaways:
Private equity continues to influence the structure and strategy of healthcare in powerful ways. Vision and strategy are the keys to success when investing in medical practices. The resilient and long-term thinking of the firms at the conference will shape the future of healthcare portfolios.
In our evolving landscape, smart data is the keystone of success. Reimbursement insights, payer disparities, and procedure-level data are essential for strategic decisions. Better reimbursement is more important now than ever. It supports liquidity, increases revenue, improves EBITDA, offsets declining Medicaid rates, guides vision-grounded growth, informs capital investments, and builds the kind of organization that younger providers value.